re. Steris (STE), the co. looks good. The valuation looks good, but
not incredibly cheap.
here's a marketguide report:
Steris Corporation SYMBOL: STE EXCHANGE: NYSE
PRICING DATA (AS OF) 07/16/99 RATIOS & STATISTICS
Price 18.94 Price/Revenue (TTM) 1.68
52 Week High 35.88 P/E (TTM) 15.76
52 Week Low 15.13 Price/Book (MRQ) 2.95
Beta 0.71 Price/Cash Flow (TTM) 11.32
Avg Daily Vol (10 Day) 0.40 Mil ROA (TTM) 10.57%
Avg Daily Vol (3 Month) 0.77 Mil ROE (TTM) 21.40%
Current Ratio (MRQ) 2.50
DIVIDEND INFORMATION Total Debt/Equity (MRQ) 0.51
Indicated Annual ($) 0.00
Yield 0.00% NOTE: TTM = trailing twelve months
MRQ = most recent quarter
SHARE RELATED INFORMATION SHORT INTEREST INFORMATION
Market Cap. ($) 1,274.016 Mil Current Month 2.600 Mil
Shares Out. 67.273 Mil Previous Month 2.783 Mil
Float 57.900 Mil Short Interest Ratio 4.1 Day
INSTITUTIONAL & INSIDER OWNERSHIP
PURCHASES SALES NET PURCH %OWNED
Institutions (3 Months) 17.863 Mil 17.147 Mil 0.716 Mil 90.8%
Insiders (6 Months) 0.000 Mil 0.454 Mil -0.454 Mil 13.9%
BUSINESS SUMMARY
STE develops, manufactures and markets, infection
prevention, contamination prevention, microbial reduction
and surgical support systems, products, services and
technologies for healthcare, scientific, food, research and
industrial customers. For the FY ended 3/31/99, revenues
rose 11% to $797.6M. Net income rose 30% to $84.9M. Results
reflect higher sales of capital equipment, consumable
products and equipment and an improved gross profit margin.
REVENUES (Thousands of U.S. Dollars)
QUARTERS 1996 1997 1998 1999
JUN 120,871 127,868 155,134 173,775
SEP 132,268 138,490 173,383 191,125
DEC 163,623 151,005 186,639 205,794
MAR 117,850 170,489 204,500 226,917
TOTAL 534,612 587,852 719,656 797,611
EARNINGS PER SHARE
JUN 0.135 -1.080 0.170 0.205
SEP 0.105 0.165 0.220 0.270
DEC 0.250 0.190 0.260 0.330
MAR 0.100 0.225 0.290 0.410
TOTAL 0.590 -0.500 0.940 1.215
8/98, 8/95, 2-for-1 splits. Fncls. prior to 6/92 are pro
forma. Increased shs reflect the 5/96 pooling of interests
merger of AMSCO. FY'95 & FY'96 restated for AMSCO merger
COMPANY COMPARISON
TO THE HEALTH CARE AND S&P 500 AGGREGATES
COMPANY INDUSTRY % S&P 500
PROFITABILITY RATIOS:
Net Profit Margin 10.64 3.25 327.4% 11.23
Return on Equity 21.40 7.05 303.6% 22.06
Interest Coverage 12.70 4.29 296.2% 8.36
VALUATION RATIOS:
P/E Ratio 15.76 24.57 64.1% 37.12
Dividend Yield 0.00 1.04 0.0% 1.20
Price to Tangible Book 5.65 6.67 84.7% 11.99
Price to Book 2.95 2.64 111.9% 9.19
Price to Free Cash Flow -104.05 42.52 -244.7% 45.34
FINANCIAL STRENGTH RATIOS:
Current Ratio 2.50 1.97 127.4% 1.49
LT Debt to Equity 0.51 0.85 59.9% 0.85
Total Debt to Equity 0.51 0.93 55.2% 1.04
GROWTH STATISTICS:
3 Yr Rev Growth 14.27 30.37 47.0% 15.07
3 Yr EPS Growth 27.13 6.86 395.3% 15.57
3 Yr Div Growth NM 4.19 NM% 10.75
Reinvestment Rate 100.00 96.79 103.3% 70.62 |
